7 completed. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 7 |
| Phase 2 | 1 | Completed 1 |
Follow Chronic Bronchitis: new trials by email Literature Review of Chronic Bronchitis trials Research Report on Chronic Bronchitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial Roflumilast, Azithromycin - Chronic Obstructive Pulmonary Disease Severe, Chronic Bronchitis | Phase 3 | Completed | Johns Hopkins University | 1032 | 2020-02-11 | 2026-08-21 |
| The Effect of Azithromycin in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Productive Cough azithromycin, placebo - Cough, Chronic Obstructive Pulmonary Disease | Phase 3 | Completed | Isala | 84 | 2009-09-01 | 2015-09-18 |
| Helium:Oxygen Noninvasive Positive Pressure Ventilation in Patients Exposed to Sulfur Mustard helium:oxygen mixture - Bronchiolitis, Chronic Bronchitis | Phase 2 / Phase 3 | Completed | Baqiyatallah Medical Sciences University | 23 | 2007-04-01 | 2008-03-25 |
| A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB) Moxifloxacin Placebo, Moxifloxacin, Azithromycin SR Placebo - Chronic Bronchitis | Phase 3 | Completed | Pfizer | 398 | 2006-02-01 | 2009-11-11 |
| To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD arformoterol, Salmeterol - Chronic Obstructive Pulmonary Disease, Chronic Bronchitis | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 799 | 2002-06-01 | 2012-02-22 |
| Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD arformoterol tartrate inhalation solution, Salmeterol, Placebo - Chronic Obstructive Pulmonary Disease, Chronic Bronchitis | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 741 | 2002-04-01 | 2012-02-22 |
| A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis. levofloxacin, azithromycin, amoxicillin/clavulanate - Bronchitis, Chronic Bronchitis | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 659 | 2001-11-01 | 2010-04-28 |
Bronchitis, Chronic (7) · Pulmonary Disease, Chronic Obstructive (4) · Emphysema (2) · Bronchiolitis (1) · Bronchitis (1) · Chronic Cough (1) · Cough (1)
Bronchial Diseases (7) · Chronic Disease (7) · Disease Attributes (7) · Infections (7) · Lung Diseases (7) · Lung Diseases, Obstructive (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Respiratory Tract Diseases (7) · Respiratory Tract Infections (7) · Bronchitis (6) · Pulmonary Disease, Chronic Obstructive (3) · Respiration Disorders (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1)
Azithromycin (3) · Formoterol Fumarate (2) · Salmeterol Xinafoate (2) · Amoxicillin (1) · Clavulanic Acid (1) · Levofloxacin (1) · Moxifloxacin (1) · Roflumilast (1)
Sumitomo Pharma America, Inc. (2) · Baqiyatallah Medical Sciences University (1) · Isala (1) · Johns Hopkins University (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · Pfizer (1)
United States (3) · China (1) · Iran (1) · Malaysia (1) · Netherlands (1) · Philippines (1) · Singapore (1) · Taiwan (1) · Thailand (1)
Jerry Krishnan, MD, PhD (1) · Robert Wise, MD (1)